Research

Pantesin May Lower LDL Cholesterol

A recently clinical study published in Nutrition Research showed Pantesin, a highly absorbable and biologically active form of vitamin B5 from Kyowa Hakko, may significantly lower LDL cholesterol levels.

The triple-blind, placebo/diet controlled trial included participants with low to moderate risk of cardiovascular disease. After 16 weeks, the group taking Pantesin saw significant drops in LDL levels in relation to the placebo group. Results are especially noteworthy, as prior studies have shown that each 1 mg/DL reduction in LDL cholesterol lowers cardiovascular disease risk by 1%. For further information: www.kyowa-usa.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters